We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Laser Corrects Blockage of Deviated Septum

By HospiMedica staff writers
Posted on 29 Aug 2002
A new laser procedure requires only a local anesthetic and is effective in treating nasal obstruction associated with a deviated septum, according to an article in the July-September 2002 issue of the Archives of Facial Plastic Surgery.

Traditional surgery uses a scalpel to cut away flaps inside the nose and reshape the cartilage manually. More...
Stitches are needed to close the surgical wounds. The new procedure uses a laser to heat the malformations until they are soft enough to be pressed or formed so that they are no longer blocking the nasal passageways. Researchers at Moscow State University (Russia) and colleagues used the laser procedure on 110 patients between 11 and 66 years old. The patients were followed for an average of 18 months.

The laser procedure lasted only six to eight minutes. The researchers found that 84 (76%) of the patients had an improvement in their airways and with symptoms associated with nasal blockages. The septal cartilage in all of the patients tended to recover some of the initial deformity after seven to 10 days. Two to three weeks later, the cartilage began to restraighten, and the septum reached a stable shape after three to four weeks. This shape change remained stable for two to three years. In 27 patients (24%), abnormalities treated with the laser resumed their original shapes. These patients had spurs or other abnormalities, did not receive uniform heating of the cartilage, and had other disorders, such as rhinitis, a chronic allergic condition causing breathing problems,

"Our results in 110 patients using this new laser-based procedure to reshape the nasal septum may provide an alternative to classic operations for reducing morbidity, operating room times, and the economic impact of time lost from work,” said Yuri Ovchinnikov, M.D., of Moscow State University.




Related Links:
Moscow State University

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.